• Sonuç bulunamadı

Comparison of neuromuscular action of recuronium, a new steroidal non-depolarizing agent, with vecuronium.

N/A
N/A
Protected

Academic year: 2021

Share "Comparison of neuromuscular action of recuronium, a new steroidal non-depolarizing agent, with vecuronium."

Copied!
1
0
0

Yükleniyor.... (view fulltext now)

Tam metin

(1)

Comparison of neuromuscular action of recuronium, a new

steroidal non-depolarizing agent, with vecuronium.

戴裕庭

Lin PL;Liu CC;Fan SZ;Chao A;Shin SC and Tai YT.

摘要

Abstract

BACKGROUND: Rocuronium is a new nondepolarizing muscle relaxant. It features a rapid onset and lack of histamine release: It has an intermediate onset of action as vecuronium. The purpose of this study was to compare the neuromuscular action and condition of intubation after a bolus dose of rocuronium or vecuronium (2 x ED90). We also compared the duration of relaxation after intubation and maintenance doses of each drug. METHODS: Sixty male or female patients, age 18-65, scheduled for elective surgery under general anesthesia were divided randomly into two groups (rocuronium and vecuronium group). All patients were ASA class I-II and pre-operative laboratory data were normal. Anesthesia was performed with fentanyl, isoflurane and O2.

Rocuronium 0.6 mg/kg (2 x ED90) or vecuronium 0.1 mg/kg (2 x ED90) was given during induction of anesthesia. The response of adductor pollicis was measured with acceleromyography. Neuromuscular block was maintained by bolus injection of rocuronium 0.15 mg/kg or vecuronium 0.025 mg/kg when T1 reached 25% of control. Onset time, duration, recovery indices, intubation condition and T4/T1 ratio to 70% were recorded. Side effects were recorded during the study. RESULTS: The onset time was significantly longer in vecuronium group than that of rocuronium group (102.8 +/- 26.9 s vs. 54.9 +/- 10.9 s, p < 0.05). The clinical durations of action were

respectively 44.2 +/- 13.2 min in rocuronium group and 42.5 +/- 9.1 min in vecuronium group (T1 to 25%). The duration of the maintenance were respectively 28.8 +/- 9.5 min in rocuronium group and 26.1 +/- 6.8 min in vecuronium group (T1 to 25%). No adverse effect occurred with either drug. The intubation condition was similar in both groups. CONCLUSIONS: We conclude that rocuronium provides a more rapid onset of action than that of vecuronium. Rocuronium is an intermediate-acting muscle relaxant as vecuronium with good to excellent intubation condition. It may be an useful alternative to vecuronium for rapid tracheal intubation.

Referanslar

Benzer Belgeler

The T-test results show significant differences between successful and unsuccessful students in the frequency of using the six categories of strategies except

When the regular Sturm–Liouville eigenvalue problem (8)-(10) is solved, there are …ve di¤erent cases depending on the value of the parameter h in the boundary condition.. In

The dose of rocuronium applied, the dose of sugammadex, the duration of the operation and anesthesia, time elapsed from the latest dose of rocuronium to sugammadex appli- cation

The present study aimed to compare the effects of NMES and endurance training on HRQOL, exercise capacity, muscle strength, dyspnea, and psychologi- cal status and body composition

Similarly, some indicators related to the environmental performance of the European member countries transport systems are identi- fied, the annually collected related data have

This type of letter serves as an alternative to a resume and cover letter, particularly if your background and reasons for interest in a specific job cannot be

Muscular dystrophy, dystrophin negative Muscular dystrophy, dystrophin positive Neuropathy/ spinal muscular atrophy Metabolic / mitochondrial myopathy inflammatory.. Patient

[r]